About this trial
The goal of this observational study is to identify differential traits in spontaneous migraine attacks that can help us predict the response to treatment with sumatriptan.
Participants will be asked to register the headache characteristics before and after taking sumatriptan and whether the treatment was effective or not during four migraine attacks.
Eligibility criteria
Qualifiers
Migraine with or without aura diagnosis according to ICHD-3 criteria
<8 migraine days per month
Be able to read, write and understand instructions.
Have internet access and mail address
Disqualifiers
Active preventive treatment for migraine
Active medication with an effect over the central nervous system
Serious physical or psychiatric condition
Cardiovascular or hepatic disease
Trial design
Treatments tested in this trial
- Sumatriptan
Treatment groups
Locations
1Sponsors and collaborators
Hospital Universitari Vall d'Hebron Research Institute
Lead sponsor
Instituto de Salud Carlos III
Collaborator